Financials
Value Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 3.9 M6.16 M5.22 M — Research & development 2.49 M1.76 M2.31 M — Operating income 27.25 M26.81 M25.07 M — Non-Operating Income, Total —-32 K-96 K — Interest expense, net of interest capitalized 00— — Non-Operating Income, excl. Interest Expenses —-32 K-96 K — Unusual income/expense ——— — Pretax income 28.35 M28.85 M27.59 M — Equity in earnings ——— — Taxes 7.2 M6.87 M7.18 M — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations 21.15 M21.98 M20.41 M — Discontinued operations 00— — Net income 21.15 M21.98 M20.41 M — Dilution adjustment -1.03 M0— — Preferred dividends 00— — Diluted net income available to common stockholders 20.12 M21.98 M19.84 M — Basic earnings per share (Basic EPS) 0.250.260.22 — Diluted earnings per share (Diluted EPS) 0.250.260.22 — Average basic shares outstanding 78.74 M80.17 M88.38 K — Diluted shares outstanding 78.74 M80.17 M88.38 K — EBITDA 27.87 M27.4 M25.64 M — EBIT 27.25 M26.81 M25.07 M — Cost of revenue 21.39 M18.44 M22.79 M — Other cost of goods sold 5.09 M1.96 M4.98 M — Depreciation & amortization (cash flow) 622 K585 K570 K —